Dashboard
Manage Tickers

OABIOmniAb, Inc.

Nasdaq N/A


$ 4.43 $ -0.10 (-2.2 %)    

Friday, 17-May-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 4.45
$ 4.53
$ 4.43 x 378
$ 0.00 x 0
$ 4.43 - $ 4.55
$ 3.78 - $ 6.72
431,278
na
448.36M
$ 2.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-25-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-20-2022 03-31-2022 10-Q
10 03-25-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 09-23-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

omniab-to-present-high-throughput-single-b-cell-screening-xploration-data-at-the-20th-annual-pegs-boston-summit
OmniAb To Present High-Throughput Single B...
05/15/2024 20:28:26

Technical synergies between xPloration, OmniFlic®, OmniClic® and OmniDeep®enable new bispecific antibody discovery workflows fo...

benchmark-reiterates-buy-on-omniab-maintains-8-price-target
Benchmark Reiterates Buy on OmniAb, Mainta...
05/14/2024 15:46:08

Benchmark analyst Robert Wasserman reiterates OmniAb (NASDAQ:OABI) with a Buy and maintains $8 price target.

omniab-q1-2024-gaap-eps-019-misses-016-estimate-sales-3801m-miss-5868m-estimate
OmniAb Q1 2024 GAAP EPS $(0.19) Misses $(0...
05/09/2024 20:27:50

OmniAb (NASDAQ:OABI) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.16) by 1...

truist-securities-maintains-buy-on-omniab-maintains-10-price-target
Truist Securities Maintains Buy on OmniAb,...
03/26/2024 13:18:28

Truist Securities analyst Robyn Karnauskas maintains OmniAb (NASDAQ:OABI) with a Buy and maintains $10 price target.

over-1m-bet-on-omniab-check-out-these-3-stocks-insiders-are-buying
Over $1M Bet On OmniAb? Check Out These 3 ...
03/26/2024 12:40:44

Although U.S. stocks closed lower on Monday, there were a few notable insider trades.

benchmark-reiterates-buy-on-omniab-maintains-8-price-target
Benchmark Reiterates Buy on OmniAb, Mainta...
03/22/2024 17:32:49

Benchmark analyst Robert Wasserman reiterates OmniAb (NASDAQ:OABI) with a Buy and maintains $8 price target.

hc-wainwright--co-reiterates-buy-on-omniab-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Omni...
03/21/2024 15:30:07

HC Wainwright & Co. analyst Joseph Pantginis reiterates OmniAb (NASDAQ:OABI) with a Buy and maintains $11 price target.

rbc-capital-reiterates-outperform-on-omniab-maintains-7-price-target
RBC Capital Reiterates Outperform on OmniA...
03/21/2024 15:10:44

RBC Capital analyst Conor McNamara reiterates OmniAb (NASDAQ:OABI) with a Outperform and maintains $7 price target.

recap-omniab-q4-earnings
Recap: OmniAb Q4 Earnings
03/20/2024 20:20:12

omniab-q4-2023-gaap-eps-014-beats-015-estimate-sales-4822m-miss-7467m-estimate
OmniAb Q4 2023 GAAP EPS $(0.14) Beats $(0....
03/20/2024 20:17:19

OmniAb (NASDAQ:OABI) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.6...

earnings-scheduled-for-march-20-2024
Earnings Scheduled For March 20, 2024
03/20/2024 09:32:15

Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per s...

earnings-preview-for-omniab
Earnings Preview For OmniAb
03/19/2024 15:00:40

omniab-presents-new-scientific-data-on-its-omnidab-platform-at-the-2023-antibody-engineering--therapeutics-conference
OmniAb Presents New Scientific Data On Its...
12/14/2023 21:36:42

Introduces the functionality and benefits of the first and only transgenic chicken producing single-domain antibodies to antibo...

benchmark-reiterates-buy-on-omniab-maintains-8-price-target
Benchmark Reiterates Buy on OmniAb, Mainta...
11/14/2023 13:36:51

Benchmark analyst Robert Wasserman reiterates OmniAb (NASDAQ:OABI) with a Buy and maintains $8 price target.

omniab-highlights-omnidab-launch-and-its-expanding-drug-discovery-platform-at-todays-research--technology-virtual-event
OmniAb Highlights OmnidAb Launch And Its E...
11/10/2023 00:10:20

Webcast and event slides available hereOmniAb, Inc. (NASDAQ:OABI) held its first Research & Technology virtual event earlie...

omniab-q3-eps-016-misses-014-estimate-sales-548m-miss-1033m-estimate
OmniAb Q3 EPS $(0.16) Misses $(0.14) Estim...
11/09/2023 13:06:37

OmniAb (NASDAQ:OABI) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.14) by 1...

earnings-scheduled-for-november-9-2023
Earnings Scheduled For November 9, 2023
11/09/2023 11:52:51

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

fisker-intercept-pharmaceuticals-immunovant-and-other-big-stocks-moving-higher-on-tuesday
Fisker, Intercept Pharmaceuticals, Immunov...
09/26/2023 14:49:13

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in ...

hc-wainwright--co-reiterates-buy-on-omniab-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Omni...
08/11/2023 12:07:48

HC Wainwright & Co. analyst Joseph Pantginis reiterates OmniAb (NASDAQ:OABI) with a Buy and maintains $11 price target.

omniab-q2-eps-015-misses-012-estimate-sales-690m
OmniAb Q2 EPS $(0.15) Misses $(0.12) Estim...
08/10/2023 20:08:35

OmniAb (NASDAQ:OABI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.12) by 2...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION